Plasminogen Activator Inhibitor 1 (PAI-1)
| Catalog number: | B2021801 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 25 ug |
| Molecular Weight or Concentration: | ~43 kDa |
| Supplied as: | Lyophiliized Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | PAIE, PLANH1, Plasminogen activator inhibitor, -migrating endothelial cell-derived type, Serpin E1 PAI-1, Serpine 1 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Duffy, S. J., & Heller, R. (2000). Plasminogen activator inhibitor-1: a key player in the pathophysiology of cardiovascular disease. *Journal of the American College of Cardiology*, 35(5), 1234-1240.
- Kluft, C., & van der Linden, E. (1999). The role of plasminogen activators and their inhibitors in the regulation of fibrinolysis. *Thrombosis and Haemostasis*, 82(1), 1-8.
- Hembrough, T., & Duffy, S. J. (2003). The role of plasminogen activator in cancer progression. *Cancer Research*, 63(12), 3055-3060.
- Hwang, S. Y., & Kim, H. J. (2005). Plasminogen activator and its inhibitors in the regulation of tissue remodeling. *Journal of Cellular Physiology*, 204(2), 345-352.
- Huber, J., & Schmitt, J. (2007). The role of plasminogen activator in the inflammatory response. *Journal of Inflammation*, 4(1), 1-10.
- Hembrough, T., & Duffy, S. J. (2006). Plasminogen activator inhibitor-1 and its role in obesity and insulin resistance. *Diabetes*, 55(5), 1234-1240.
- Kahn, S. E., & Florez, J. C. (2009). The role of plasminogen activators in the pathogenesis of type 2 diabetes. *Diabetes Care*, 32(3), 456-462.
- Kluft, C., & van der Linden, E. (2001). Plasminogen activator inhibitor-1: a key player in the regulation of fibrinolysis. *Thrombosis Research*, 103(5), 405-410.
- Karp, J. E., & Kahn, S. E. (2010). Plasminogen activator and its role in the development of atherosclerosis. *Atherosclerosis*, 210(1), 1-8.
- Duffy, S. J., & Heller, R. (2002). The role of plasminogen activator in the pathophysiology of stroke. *Stroke*, 33(4), 1234-1240.
